Literature DB >> 25242432

The MATRICS Consensus Cognitive Battery (MCCB): performance and functional correlates.

June Ullevoldsæter Lystad1, Erik Falkum2, Christine Mohn3, Vegard Øksendal Haaland4, Helen Bull5, Stig Evensen5, Bjørn Rishovd Rund6, Torill Ueland5.   

Abstract

Neurocognitive impairment is a core feature in psychotic disorders and the MATRICS Consensus Cognitive Battery (MCCB) is now widely used to assess neurocognition in this group. The MATRICS has been translated into several languages, including Norwegian; although this version has yet to be investigated in an adult clinical population. Further, the relationship between the MATRICS and different measures of functioning needs examination. The purpose of this study was to describe neurocognition assessed with the Norwegian version of the MATRICS battery in a sample of patients with psychotic disorders compared to age and gender matched healthy controls and to examine the association with educational-, occupational- and social-functioning in the patient group. One hundred and thirty one patients and 137 healthy controls completed the battery. The Norwegian version of the MATRICS was sensitive to the magnitude of neurocognitive impairments in patients with psychotic disorders, with patients displaying significant impairments on all domains relative to healthy controls. Neurocognition was also related to both self-rated and objective functional measures such as social functioning, educational- and employment-history.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Functional correlates; MATRICS; Neurocognition; Psychosis; Social functioning; Vocational rehabilitation

Mesh:

Year:  2014        PMID: 25242432     DOI: 10.1016/j.psychres.2014.08.060

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  10 in total

1.  What is the optimal neuropsychological test battery for schizophrenia in China?

Authors:  Chuan Shi; Lan Kang; Shuqiao Yao; Yibin Ma; Tao Li; Ying Liang; Zhang Cheng; Yifeng Xu; Jianguo Shi; Xiufeng Xu; Congpei Zhang; Donald R Franklin; Robert K Heaton; Hua Jin; Xin Yu
Journal:  Schizophr Res       Date:  2019-02-01       Impact factor: 4.939

2.  Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.

Authors:  Karin S Walsh; Jennifer Janusz; Pamela L Wolters; Staci Martin; Bonita P Klein-Tasman; Mary Anne Toledo-Tamula; Heather L Thompson; Jonathan M Payne; Kristina K Hardy; Peter de Blank; Claire Semerjian; Laura Schaffner Gray; Sondra E Solomon; Nicole Ullrich
Journal:  Neurology       Date:  2016-08-16       Impact factor: 9.910

3.  Relationship between effortful motivation and neurocognition in schizophrenia.

Authors:  Andrew W Bismark; Michael L Thomas; Melissa Tarasenko; Alexandra L Shiluk; Sonia Y Rackelmann; Jared W Young; Gregory A Light
Journal:  Schizophr Res       Date:  2017-06-30       Impact factor: 4.939

4.  Education Mediates Racial Disparities in Cognitive Impairment Among Older Adults With Schizophrenia.

Authors:  Sarah Dobbins; Erin Hubbard; Heather Leutwyler
Journal:  Clin Gerontol       Date:  2021-02-12       Impact factor: 2.871

5.  Vocational rehabilitation for adults with psychotic disorders in a Scandinavian welfare society.

Authors:  Erik Falkum; Ole Klungsøyr; June Ullevoldsæter Lystad; Helen Christine Bull; Stig Evensen; Egil W Martinsen; Svein Friis; Torill Ueland
Journal:  BMC Psychiatry       Date:  2017-01-17       Impact factor: 3.630

6.  Alpha7 nAChR Agonists for Cognitive Deficit and Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Double-blind Controlled Trials.

Authors:  Ye Jin; Qi Wang; Yan Wang; Mengxi Liu; Anji Sun; Zhongli Geng; Yiwei Lin; Xiaobai Li
Journal:  Shanghai Arch Psychiatry       Date:  2017-08-25

7.  Relationship between social and cognitive functions in people with schizophrenia.

Authors:  Takeo Tominaga; Masahito Tomotake; Tomoya Takeda; Yoshinori Ueoka; Tsunehiko Tanaka; Shin-Ya Watanabe; Naomi Kameoka; Masahito Nakataki; Shusuke Numata; Yumiko Izaki; Satsuki Sumitani; Hiroko Kubo; Yasuhiro Kaneda; Tetsuro Ohmori
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-30       Impact factor: 2.570

8.  Validity of remote administration of the MATRICS Consensus Cognitive Battery for individuals with severe mental illness.

Authors:  Madisen T Russell; Kensie M Funsch; Cassi R Springfield; Robert A Ackerman; Colin A Depp; Philip D Harvey; Raeanne C Moore; Amy E Pinkham
Journal:  Schizophr Res Cogn       Date:  2021-12-02

9.  Prevalence, profile and associations of cognitive impairment in Ugandan first-episode psychosis patients.

Authors:  Emmanuel K Mwesiga; Reuben Robbins; Dickens Akena; Nastassja Koen; Juliet Nakku; Noeline Nakasujja; Dan J Stein
Journal:  Schizophr Res Cogn       Date:  2021-12-30

10.  Reverse translated and gold standard continuous performance tests predict global cognitive performance in schizophrenia.

Authors:  Andrew W Bismark; Michael L Thomas; Melissa Tarasenko; Alexandra L Shiluk; Sonia Y Rackelmann; Jared W Young; Gregory A Light
Journal:  Transl Psychiatry       Date:  2018-04-12       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.